Strategic Focus Target thoracic procedure markets with sternal closure, rib stabilization, and chest wall reconstruction solutions, aligning sales outreach with hospitals performing high-volume sternotomy and trauma surgeries in the Pacific Northwest.

Mid-market Potential Acute Innovations operates with 11-50 employees and annual revenue in the low millions, presenting opportunities with regional medtech distributors and hospital supply chains that serve mid-sized medical centers looking for specialized chest wall devices.

Product Portfolio Leverage and cross-sell AcuTie II, BioBridge, and RibLoc chest wall systems to expand contracts with surgeons and purchasing committees focused on faster recovery, reduced complications, and improved thoracic outcomes.

Competitive Positioning Distinguish through focused thoracic solutions as a niche provider among larger additive and general device players, positioning as a partner for implementation support, training, and post-market clinical evidence in trauma and cardiothoracic programs.

Growth Signals Engage hospitals expanding thoracic capabilities or investing in chest wall stabilization; pair outreach with case studies, clinical data, and references from comparable mid-sized manufacturers to accelerate trial adoption and new product onboarding.